The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
RRIA (Rapid Response Innovation Awards), 2013Physiological Mechanism Underlying Alpha Synuclein-driven Oxidant Stress
Objective/Rationale:
The formation of alpha-synuclein inclusions is the cardinal pathology of Parkinson’s disease (PD). Their appearance is accompanied by free radical (unstable atoms or... -
RRIA (Rapid Response Innovation Awards), 2013Dietary Lectins and Parkinson’s Disease
Objective/Rationale:
Recently it has been suggested that ingested environmental toxins may trigger a series of events, starting in the gastrointestinal tract, that eventually result in... -
Rapid Response Innovation Awards, 2013Regulation of Tau Protein by MicroRNA
Objective/Rationale:
We propose studies to address the overall hypothesis that small ribonucleic acids (RNAs) – molecules that code and regulate genes –contribute to the type of tau protein... -
Research Grant, 2013Identification of RNAs in Carrier Protein and Exosomes Compared to RNA Found in the Whole Sample
Objective/Rationale:
Isolation of RNA biomarkers from biofluids is a new promising approach to monitor health and disease. RNAs exist in different fractions of cell-free biofluids. Some are... -
Research Grant, 2013Inhaled Levodopa as a Treatment for Intermittent Motor Fluctuations in Parkinson’s Disease
Promising Outcomes of Original Grant:
Intrapulmonary delivery of levodopa results in rapid, consistent and predictable augmentation of plasma levodopa levels in both healthy volunteers and subjects... -
Rapid Response Innovation Awards, 2013Neuroprotectin D1 (NPD1) as a Disease-modifying Therapy for Parkinson’s Disease
Objective/Rationale:
Progressive loss of dopaminergic neurons in Parkinson’s disease (PD) involves several pathogenic mechanisms. It may be assumed that drugs acting on more than one...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.